Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06509126
What this trial is testing

Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IV
National Cancer Institute, Naples 500
Testing effectiveness (Phase 2)WithdrawnNCT01293942
What this trial is testing

IXO+A in mCRC With Liver-only Metastases

Who this might be right for
Metastatic Colorectal Cancer
Ottawa Hospital Research Institute
Testing effectiveness (Phase 2)UnknownNCT03567629
What this trial is testing

Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

Who this might be right for
mCRC
Peking University 130
Large-scale testing (Phase 3)Ended earlyNCT03654729
What this trial is testing

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Who this might be right for
Colorectal CancerChemotherapy-induced Peripheral Neuropathy
Egetis Therapeutics AB (publ) 291
Large-scale testing (Phase 3)Not Yet RecruitingNCT07595276
What this trial is testing

Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.

Who this might be right for
Colorectal Cancer
Taizhou Mabtech Pharmaceutical Co.,Ltd 608
Testing effectiveness (Phase 2)Study completedNCT01345526
What this trial is testing

Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream

Who this might be right for
Metastatic Colorectal Cancer
Universitätsmedizin Mannheim 124
Testing effectiveness (Phase 2)Looking for participantsNCT06218810
What this trial is testing

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerMicrosatellite Stable Colorectal CarcinomaRAS Mutation+1 more
Fudan University 53
Testing effectiveness (Phase 2)UnknownNCT04380103
What this trial is testing

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic CancerColorectal CancerColorectal Adenocarcinoma
Chinese Academy of Medical Sciences 106
Large-scale testing (Phase 3)Study completedNCT00719797
What this trial is testing

Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 509
Large-scale testing (Phase 3)UnknownNCT03783559
What this trial is testing

TACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Fudan University 168
Testing effectiveness (Phase 2)Study completedNCT02384759
What this trial is testing

Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 117
Not applicableUnknownNCT04852250
What this trial is testing

Centralized Tumour Board and Secondary Intervention Rate in mCRC

Who this might be right for
Metastatic Colorectal CancerRAS MutationMultidisciplinary Communication+1 more
Ludwig-Maximilians - University of Munich 130
Testing effectiveness (Phase 2)Study completedNCT00039208
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT00384176
What this trial is testing

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Who this might be right for
Colorectal Cancer
AstraZeneca 1,814
Not applicableStudy completedNCT00537901
What this trial is testing

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Who this might be right for
Colonic NeoplasmsRectal Neoplasms
King Faisal Specialist Hospital & Research Center 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446387
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 70
Large-scale testing (Phase 3)Study completedNCT00115765
What this trial is testing

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

Who this might be right for
Colorectal Cancer
Amgen 1,053
Testing effectiveness (Phase 2)Study completedNCT01051167
What this trial is testing

Bi-weekly Cetuximab Combined With 5-fluorouracil/Leucovorin/Oxaliplatin (FOLFOX-6) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Martin Schuler, Prof. Dr. med. 59
Testing effectiveness (Phase 2)UnknownNCT04866108
What this trial is testing

A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Beijing Friendship Hospital 49
Early research (Phase 1)Study completedNCT01286818
What this trial is testing

Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)

Who this might be right for
Colorectal Carcinoma
Eli Lilly and Company 6
Next Page